Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-02-07 @ 5:12 PM
Study NCT ID:
NCT02036060
Status:
COMPLETED
Last Update Posted:
2020-11-16
First Post:
2014-01-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.
Sponsor:
Spanish Oncology Genito-Urinary Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ABIDO-SOGUG
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None